Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Fusion Pharmaceuticals Inc. | 0 | reported | 04 Jun 2024 | tx 16+278,411−278,411 |
| Xenon Pharmaceuticals Inc. | 0 | reported | 12 May 2026 | tx 22+157,462−21,647 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,500 | 7.38 USD | |
| 12 May 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 3,500 | 0.00 USD | deriv |
| 05 Jun 2025 | SALE | Xenon Pharmaceuticals Inc. | 3 | 30.48 USD | |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 17,012 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 2,645 | 0.00 USD | deriv |
| 14 May 2025 | EXERCISE | Xenon Pharmaceuticals Inc. | 5,144 | 12.57 USD | |
| 14 May 2025 | EXERCISE | Xenon Pharmaceuticals Inc. | 5,144 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 15,542 | 0.00 USD | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 56,400 | — | |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 17,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 17,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 17,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 30,000 | — | deriv |
| 04 Jun 2024 | OTHER | Fusion Pharmaceuticals Inc. | 141,011 | — | deriv |
| 07 Mar 2024 | SALE | Xenon Pharmaceuticals Inc. | 5,000 | 46.30 USD | |
| 07 Mar 2024 | SALE | Xenon Pharmaceuticals Inc. | 5,000 | 46.25 USD | |
| 07 Mar 2024 | SALE | Xenon Pharmaceuticals Inc. | 2,000 | 46.20 USD | |
| 07 Mar 2024 | SALE | Xenon Pharmaceuticals Inc. | 1,000 | 46.45 USD | |
| 14 Jun 2023 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 17,000 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 18,475 | 0.00 USD | deriv |
| 11 Aug 2022 | PURCHASE | Fusion Pharmaceuticals Inc. | 44,400 | 2.03 USD | |
| 28 Jun 2022 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 18,000 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Fusion Pharmaceuticals Inc. | 17,000 | 0.00 USD | deriv |
| 23 Aug 2021 | PURCHASE | Fusion Pharmaceuticals Inc. | 2,829 | 7.99 USD | |
| 18 Aug 2021 | PURCHASE | Fusion Pharmaceuticals Inc. | 171 | 8.05 USD |
1 purchase reported after at least 12 months of silence — most recent on 16 Aug 2021.